DK489378A - 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse - Google Patents

6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse

Info

Publication number
DK489378A
DK489378A DK489378A DK489378A DK489378A DK 489378 A DK489378 A DK 489378A DK 489378 A DK489378 A DK 489378A DK 489378 A DK489378 A DK 489378A DK 489378 A DK489378 A DK 489378A
Authority
DK
Denmark
Prior art keywords
dioxopregnan
oxygenated
procedures
derivatives
preparation
Prior art date
Application number
DK489378A
Other languages
Danish (da)
English (en)
Inventor
R W Draper
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DK489378A publication Critical patent/DK489378A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073Sulfur-containing hetero ring
    • C07J71/0089Sulfur-containing hetero ring containing sulfur and oxygen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK489378A 1977-11-08 1978-11-02 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse DK489378A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/849,563 US4201778A (en) 1977-11-08 1977-11-08 6-Acyloxy-1,4,6-pregnatrienes, their use as anti-inflammatory agents, methods for their manufacture, and 6-oxo-1,4-pregnadiene intermediates

Publications (1)

Publication Number Publication Date
DK489378A true DK489378A (da) 1979-05-09

Family

ID=25306004

Family Applications (1)

Application Number Title Priority Date Filing Date
DK489378A DK489378A (da) 1977-11-08 1978-11-02 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse

Country Status (9)

Country Link
US (1) US4201778A (xx)
EP (1) EP0001864A1 (xx)
JP (1) JPS5473765A (xx)
AU (1) AU4127478A (xx)
DK (1) DK489378A (xx)
FI (1) FI783340A (xx)
IL (1) IL55862A0 (xx)
IT (1) IT1099828B (xx)
ZA (1) ZA786054B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5792758A (en) * 1995-12-08 1998-08-11 G. D. Searle & Co. Steroid nitrite ester derivatives useful as anti-inflammatory drugs
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US10231979B2 (en) * 2015-08-07 2019-03-19 Indiana University Research And Technology Corporation Modulation of inflammation using progesterone metabolites

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1184505A (fr) * 1955-06-07 1959-07-22 Scherico Ltd Procédé de préparation de composés stéroïdes de la série du prégnane
US3079301A (en) * 1956-04-25 1963-02-26 Schering Corp 9alpha-halo-1, 4, 6-pregnatrienes and therapeutic compositions containing same
US2816902A (en) * 1957-01-14 1957-12-17 Schering Corp Hydroxylated steroids
US2937975A (en) * 1958-08-18 1960-05-24 Pfizer & Co C Steroid halohydrins and process therefor
US2887499A (en) * 1958-11-13 1959-05-19 Schering Corp Hydroxylated steroid intermediates and methods for their manufacture
US3032565A (en) * 1960-08-24 1962-05-01 Searle & Co Process for the manufacture of 6-alkoxy-and 6-keto steroids and compounds obtained thereby
US3071580A (en) * 1961-04-28 1963-01-01 American Cyanamid Co 6beta-hydroxy-16alpha, 17alpha-alkylidendioxy-11-oxygenated pregnenes
US3131181A (en) * 1961-05-29 1964-04-28 American Cyanamid Co Method of preparing 6-hydroxy pregnenes and pregnadienes and products resulting therefrom
US3629303A (en) * 1969-06-09 1971-12-21 Schering Corp 6-alkoxy - 16 - alkylidene - 17alpha - lower alkanoyloxy-21-desoxy - 4 6 - pregnadienes methods for their manufacture and intermediates produced thereby
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4076708A (en) * 1976-12-22 1978-02-28 Schering Corporation Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby

Also Published As

Publication number Publication date
EP0001864A1 (en) 1979-05-16
AU4127478A (en) 1979-05-17
IL55862A0 (en) 1979-01-31
JPS5473765A (en) 1979-06-13
IT1099828B (it) 1985-09-28
US4201778A (en) 1980-05-06
ZA786054B (en) 1979-10-31
IT7829133A0 (it) 1978-10-26
FI783340A (fi) 1979-05-09

Similar Documents

Publication Publication Date Title
DK173778A (da) Fremgangsmaade til fremstilling af mercaptoalkylsulfonylprolinderivater og dermed beslaegtede forbindelser
DK581278A (da) Fremgangsmaade til fremstilling af aminderivater
DK148751C (da) Fremgangsmaade til fremstilling af cyclosporinderivater
DK63178A (da) Fremgangsmaade til fremstilling af pyrrodinderivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK38077A (da) Fremgangsmade til fremstilling af dinatriumcromoglycat og farmaceutiske kompositioner indeholdende dette
DK445078A (da) Fremgangsmaade til fremstilling af 4,5-dihydro-2-alkoxycarbonylamino-5-carbocyklisk arylimidazoler og derivater deraf
DK489378A (da) 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse
DK313878A (da) Indolderivater og fremgangsmaade til fremstilling deraf
DK312878A (da) Fremgangsmaade til fremstilling af indolderivater
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK267078A (da) Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf
DK300978A (da) Fremgangsmaade til fremstilling af indolderivater
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
DK571078A (da) Insekticide forbindelser fremgangsmaade til fremstilling heraf og insekticide kompositioner indeholdende disse
DK316178A (da) Fremgangsmaade til fremstilling af benzopyranderivater isaer 3-oxaloamino-4-oxo4h-1-benzopyranderivater og salte deraf
DK575678A (da) 5-(2-anilinoalkylamino-1-hydroxyalkyl) salicylamider fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
DK449276A (da) Urinstofderivater fremgangsmade til fremstilling af disse forbindelser samt herbicide midler indeholdende dem
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK345277A (da) Fremgangsmaade til fremstilling af tetrahydropyridinderivater
DK538577A (da) Isoxaolderivater fremgangsmaade til deres fremstilling og midler indeholdende disse forbindelser
DK75778A (da) Fremgangsmaade til fremstilling af 17alfaacetylenderivater af androst-4-en.
DK105078A (da) Fremgangsmaade til fremstilling af isobutyramidderivater